These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 26897389

  • 1. Effect of smoking status on the efficacy of the SMART regimen in high risk asthma.
    Pilcher J, Patel M, Reddel HK, Pritchard A, Black P, Shaw D, Holt S, Weatherall M, Beasley R.
    Respirology; 2016 Jul; 21(5):858-66. PubMed ID: 26897389
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.
    Beasley R, Holliday M, Reddel HK, Braithwaite I, Ebmeier S, Hancox RJ, Harrison T, Houghton C, Oldfield K, Papi A, Pavord ID, Williams M, Weatherall M, Novel START Study Team.
    N Engl J Med; 2019 May 23; 380(21):2020-2030. PubMed ID: 31112386
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal.
    Chapman KR, Barnes NC, Greening AP, Jones PW, Pedersen S.
    Thorax; 2010 Aug 23; 65(8):747-52. PubMed ID: 20581409
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C.
    Curr Med Res Opin; 2004 Sep 23; 20(9):1403-18. PubMed ID: 15383189
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis.
    Patel M, Pilcher J, Hancox RJ, Sheahan D, Pritchard A, Braithwaite I, Shaw D, Black P, Weatherall M, Beasley R, SMART Study Group.
    NPJ Prim Care Respir Med; 2015 Jan 08; 25():14099. PubMed ID: 25569185
    [Abstract] [Full Text] [Related]

  • 12. As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.
    Bateman ED, Reddel HK, O'Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM.
    N Engl J Med; 2018 May 17; 378(20):1877-1887. PubMed ID: 29768147
    [Abstract] [Full Text] [Related]

  • 13. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study.
    Lundborg M, Wille S, Bjermer L, Tilling B, Lundgren M, Telg G, Ekström T, Selroos O.
    Curr Med Res Opin; 2006 May 17; 22(5):809-21. PubMed ID: 16709303
    [Abstract] [Full Text] [Related]

  • 14. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
    Bisgaard H, Le Roux P, Bjåmer D, Dymek A, Vermeulen JH, Hultquist C.
    Chest; 2006 Dec 17; 130(6):1733-43. PubMed ID: 17166990
    [Abstract] [Full Text] [Related]

  • 15. Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone.
    Peters SP, Bleecker ER, Canonica GW, Park YB, Ramirez R, Hollis S, Fjallbrant H, Jorup C, Martin UJ.
    N Engl J Med; 2016 Sep 01; 375(9):850-60. PubMed ID: 27579635
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial.
    Pilcher J, Patel M, Pritchard A, Thayabaran D, Ebmeier S, Shaw D, Black P, Braithwaite I, Weatherall M, Beasley R.
    NPJ Prim Care Respir Med; 2017 May 11; 27(1):33. PubMed ID: 28496190
    [Abstract] [Full Text] [Related]

  • 18. Budesonide/formoterol pressurized metered-dose inhaler for patients with persistent asthma.
    Korenblat PE, Rosenwasser LJ.
    Allergy Asthma Proc; 2010 May 11; 31(3):190-202. PubMed ID: 20482961
    [Abstract] [Full Text] [Related]

  • 19. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr 11; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 20. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S, Vogelmeier C, Buhl R.
    Med Klin (Munich); 2008 May 15; 103(5):299-310. PubMed ID: 18484216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.